Our urine knows and says more about our health than we think

Urine is much more than just a waste product of metabolism. It reflects how our kidneys, sugar metabolism, acid-base balance, and even our current hydration levels are functioning. Systematically monitoring urine—its color, odor, quantity, and individual parameters—provides early indications of diseases that often only become clinically noticeable years later. This is precisely why urine is so central to diagnostics.

In this overview, we examine five clinical conditions where urine reveals a particularly large amount of information:

Urinary tract infections, chronic kidney disease (CKD), diabetes mellitus, urinary stones (urolithiasis), and gout.

Urinary tract infections

Urinary tract infections are among the most common bacterial infections overall, especially in women. Two markers typically appear in the urine: leukocytes as an indication of an inflammatory reaction and nitrite, which is produced by bacterial metabolic products—primarily in E. coli, by far the most common pathogen. If both are positive, a urinary tract infection is very likely; however, a negative nitrite result does not rule it out, as not all pathogens produce nitrite.

The current S3 guideline on uncomplicated urinary tract infections (AWMF 043-044) recommends not rushing to use antibiotics for typical symptoms such as burning during urination and frequent urge to urinate. Careful urine diagnostics help to avoid unnecessary treatments—and thus also resistance.

Chronic kidney disease (CKD)

Chronic kidney disease often progresses silently for many years. A crucial early marker is microalbuminuria: minute amounts of albumin that pass through the damaged renal corpuscles into the urine. In laboratory diagnostics today, the albumin-creatinine ratio (UACR) is determined in spot urine, usually combined with the estimated glomerular filtration rate (eGFR) from the blood.

The 2024 KDIGO guideline emphasizes that CKD should be screened regularly, especially in people with diabetes, high blood pressure, or a family history of kidney disease. Detected early, progression can now be significantly slowed down—using SGLT2 inhibitors and, in selected patients, finerenone.

Diabetes mellitus

In diabetes, urine is insightful in two ways. Firstly, glucose can appear in the urine if blood sugar levels exceed the renal threshold. Secondly—as with CKD—microalbumin screening is central, because diabetic nephropathy is one of the most common secondary diseases. According to current figures, a significant proportion of people with type 2 diabetes develop kidney involvement during the course of the disease.

The National Care Guideline for Type 2 Diabetes therefore recommends annual screening for albuminuria. Changes in the urine often precede changes in the eGFR by years—a window of opportunity in which much can still be achieved therapeutically.

Urinary stones (urolithiasis)

Whether someone is prone to urinary stones can be largely determined from the urine. Two parameters are particularly decisive here: the pH value and the specific gravity of the urine. Permanently acidic urine favors uric acid and cystine stones, while permanently alkaline urine favors struvite and calcium phosphate stones. A constantly high specific gravity indicates overly concentrated urine and thus insufficient fluid intake—by far the most important modifiable risk factor.

The AWMF S2k guideline on urolithiasis (043-025) estimates the recurrence rate for untreated stone patients at around 50 percent within ten years. A regular look at the urine is therefore not a gimmick, but lived metaphylaxis.

Gout

Gout is caused by elevated uric acid levels, typically in the presence of obesity, a purine-rich diet, and heavy alcohol consumption. Clinically, it usually manifests as an acute gout attack in a joint—but gout becomes urologically relevant when uric acid stones form at a low urine pH. Here too, the urine provides early indications long before a stone becomes symptomatic.

Therapeutically, in addition to medicinal uric acid reduction, diet, sufficient fluid intake, and, if necessary, alkalization of the urine play a role. Here, too, ongoing urine monitoring is the simplest and most cost-effective control parameter.

Conclusion

Urine is a diagnostic window that is used too rarely. Whether it is a urinary tract infection, beginning kidney weakness, diabetes, stone disease, or gout—many of these diseases announce themselves in the urine before they become noticeable in the blood or clinical findings. Those who keep a regular eye on urine values gain time—and time is the most important factor of all in prevention.

Sources

AWMF – S3 Guideline “Epidemiology, Diagnostics, Therapy, Prevention and Management of Uncomplicated, Bacterial Community-Acquired Urinary Tract Infections” (043-044): register.awmf.org/de/leitlinien/detail/043-044
KDIGO – “2024 Clinical Practice Guideline for the Evaluation and Management of CKD”: kdigo.org/guidelines/ckd-evaluation-and-management
BÄK, KBV, AWMF – National Care Guideline Type 2 Diabetes (NVL-001): register.awmf.org/de/leitlinien/detail/nvl-001
AWMF – S2k Guideline “Urolithiasis: Diagnostics, Therapy and Metaphylaxis” (043-025): register.awmf.org/de/leitlinien/detail/043-025
DGRh – S2e Guideline “Gouty Arthritis” (060-005): register.awmf.org/de/leitlinien/detail/060-005
Robert Koch Institute – Health Reporting “Diabetes mellitus”: rki.de/DE/Themen/Nicht-uebertragbare-Krankheiten/Diabetes